Bone marrow stem cells and liver disease

Gut

Volumn 56, Issue 5, 2007, Pages 716-724

  Kallis, Y N ^b   Alison, M R ^c   Forbes, S J ^a,d  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^d UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTITRYPSIN; ALPHA FETOPROTEIN; COLONY STIMULATING FACTOR 1; INTERLEUKIN 3; MESSENGER RNA;

ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; CELL DIFFERENTIATION; CELL FUSION; CELL POPULATION; CELL REGENERATION; CLINICAL TRIAL; FIBROGENESIS; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; LIVER CELL; LIVER CIRRHOSIS; LIVER DISEASE; LIVER FIBROSIS; LIVER INJURY; LIVER PARENCHYMA; MESENCHYMAL STEM CELL; MONOCYTE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL;

ANIMALS; CELL DIFFERENTIATION; CELL MOVEMENT; CLINICAL TRIALS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HEPATOCYTES; HUMANS; LIVER DISEASES; LIVER REGENERATION;

EID: 34247504081     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.2006.098442     Document Type: Article

References (73)

1. Overturf K, Al Dhalimy M, Ou CN, et al. Serial transplantation reveals the stem-cell-like regenerative potential of adult mouse hepatocytes. Am J Pathol 1997;151:1273-80.
2. Tatematsu M, Ho RH, Kaku T, et al. Studies on the proliferation and fate of oval cells in the liver of rats treated with 2-acetylaminofluorene and partial hepatectomy. Am J Pathol 1984;114:418-30.
3. Evarts RP, Nagy P, Nakatsukasa H, et al. In vivo differentiation of rat liver oval cells into hepatocytes. Cancer Res 1989;49:1541-7.
4. Paku S, Schnur J, Nagy P, et al. Origin and structural evolution of the early proliferating oval cells in the rat liver. Am J Pathol 2001;158:1313-23.
5. Roskams TA, Theise ND, Balabaud C, et al. Nomenclature of the finer branches of the biliary tree: canals, ductules, and ductular reaction in human livers. Hepatology 2004;39:1739-45.
6. Alison MR, Poulsom R, Jeffery R, et al. Hepatocytes from non-hepatic adult stem cells. Nature 2000;406:257.
7. Theise ND, Nimmakayalu M, Gardner R, et al. Liver from bone marrow in humans. Hepatology 2000;32:11-6.
8. Korbling M, Katz RL, Khanna A, et al. Hepatocytes and epithelial cells of donor origin in recipients of peripheral-blood stem cells. N Engl J Med 2002;346:738-46.
9. Cantz T, Sharma AD, Jochheim-Richter A, et al. Re-evaluation of bone marrow-derived cells as a source for hepatocyte regeneration. Cell Transplant 2004;13:659-66.
10. Willenbring H, Bailey AS, Foster M, et al. Myelomonocytic cells are sufficient for therapeutic cell fusion in liver. Nature Med 2004;10:744-8.
11. Menthena A, Deb N, Oertel M, et al. Bone marrow progenitors are not the source of expanding oval cells in injured liver. Stem Cells 2004;22:1049-61.
12. Vig P, Russo FP, Edwards RJ, et al. The sources of parenchymal regeneration after chronic hepatocellular liver injury in mice. Hepatology 2006;43:316-24.
13. Kashofer K, Siapati EK, Bonnet D. In vivo formation of unstable heterokaryons after liver damage and hematopoietic stem/progenitor transplantation. Stem Cells 2006;24:1104-12.
14. Newsome PN, Johannessen I, Boyle S, et al. Human cord blood-derived cells can differentiate into hepatocytes in me mouse liver with no evidence of cellular fusion. Gastroenterology 2003;124:1891-900.
15. Sharma AD, Cantz T, Richter R, et al. Human cord blood stem cells generate human cytokeratin 18-negative hepatocyte-like cells in injured mouse liver. Am J Pathol 2005;167:555-64.
16. Thorgeirsson SS, Grisham JW. Hematopoietic cells as hepatocyte stem cells: a critical review of the evidence. Hepatology 2006;43:2-8.
17. Stephenne X, Najimi M, Sibille C, et al. Sustained engraftment and tissue enzyme activity after liver cell transplantation for argininosuccinate lyase deficiency. Gastroenterology 2006;130: 1317-23.
18. Lagasse E, Connors H, Al-Dhalimy M, et al. Purified haematopoietic stem cells can differentiate into hepatocytes in vivo. Nat Med 2000;6:1229-34.
19. Quintana-Bustamante O, Alvarez-Barrientos A, Kofman AV, et al. Hematopoietic mobilization in mice increases the presence of bone marrow-derived hepatocytes via in vivo cell fusion. Hepatology 2006;43:108-16.
20. Yannaki E, Athanasiou E, Xagorari A, et al. G-CSF-primed hematopoietic stem cells or G-CSF per se accelerate recovery and improve survival after liver injury, predominantly by promoting endogenous repair programs. Exp Hematol 2005;33:108-19.
21. Yamazaki S, Miki K, Takayama T, et al. Hepatic gene induction in murine bone marrow after hepatectomy. J Hepatol 2006;44:325-33.
22. Jang YY, Collector MI, Baylin SB, et al. Haematopoietic stem cells convert into liver cells within days without fusion. Nat Cell Biol 2004;6:532-9.
23. Sato Y, Araki H, Kato J, et al. Human mesenchymal stem cells xenografted directly to rat are differentiated into human hepatocytes without fusion. Blood 2005;106:756-63.
24. Lange C, Bruns H, Kluth D, et al. Hepatocyte differentiation of mesenchymal stem cells in cocultures with fetal liver cells. World J Gastroenterol 2006;12:2394-7.
25. Ruhnke M, Ungefroren H, Nussler A, et al. Differentiation of in vitro-modified human peripheral blood monocytes into hepatocyte-like and pancreatic islet-like cells. Gastroenterology 2005;128:1774-86.
26. Schwartz RE, Reyes M, Koodie L, et al. Multipotent adult progenitor cells from bone marrow differentiate into functional hepatocyte-like cells. J Clin Invest 2002;109:1291-302.
27. Jiang Y, Jahagirdar BN, Reinhardt RL, et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 2002;418:41-9.
28. Giles J. The trouble with replication. Nature 2006;442:344- 7.
29. Chiba T, Kita K, Zheng YW, et al. Side population purified from hepatocellular carcinoma cells harbors cancer stem cell-like properties. Hepatology 2006;44:240-51.
30. Ishikawa H, Nakao K, Matsumoto K, et al. Bone marrow engraftment in a rodent model of chemical carcinogenesis but no role in the histologenesis of hepatocellular carcinoma. Gut 2004;53:884-9.
31. Abe S, Lauby G, Boyer C, et al. Transplanted BM and BM side population cells contribute progeny to the lung and liver in irradiated mice. Cytotherapy 2003;5:523-33.
32. Takezawa R, Watanabe Y, Akaike T. Direct evidence of macrophage differentiation from bone marrow cells in the liver: a possible origin of Kupffer cells. J Biochem (Tokyo) 1995;118:1175-83.
33. Fujii H, Hirose T, Oe S, et al. Contribution of bone marrow cells to liver regeneration after partial hepatectomy in mice. J Hepatol 2002;36:653-9.
34. Asohara T, Murhara T, Sullivan A, et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997;275:964-7.
35. Taniguchi E, Kin M, Torimura T, et al. Endothelial progenitor cell transplantation improves survival following liver injury in mice. Gastroenterology 2006;130:521-31.
36. Cassiman D, Barlow A, Vander Borght S, et al. Hepatic stellate cells do not derive from the neural crest. J Hepatol 2006;44:1098-104.
37. Russo FP, Alison MR, Bigger BW, et al. The bone marrow functionally contributes to liver fibrosis. Gastroenterology 2006;130:1807-21.
38. Kisselevo T, Uchinami H, Feirt N, et al. Bone marrow-derived fibrocytes participate in pathogenesis of liver fibrosis. J Hepatol 2006;45:429-38.
39. Metz CN. Fibrocytes: a unique cell population implicated in wound healing. Cell Mol Life Sci 2003;60:1342-50.
40. Mori L, Bellini A, Stacey M, et al. Fibrocytes contribute to the myofibroblast population in wounded skin and originate from the bone marrow. Exp Cell Res 2005;304:81-90.
41. Moore BB, Kolodsick JE, Thannickal VJ, et al. CCR2-mediated recruitment of fibrocytes to the alveolar space after fibrotic liver injury. Am J Pathol 2005;166:675-84.
42. Magness S, Bataller R, Yang L, et al. A dual reporter gene transgenic mouse demonstrates heterogeneity in hepatic fibrogenic cell populations. Hepatology 2004;40:1151-9.
43. Forbes SJ, Russo FP, Rey V, et al. A significant proportion of myofibroblasts are of bone marrow origin in human liver fibrosis. Gastroenterology 2004;126:955-63.
44. Brittan M, Hunt T, Jeftery R, et al. Bone marrow derivation of pericryptal myofibroblasts in the mouse and human small intestine and colon. Gut 2002;50:752-7.
45. Broker V, Longer F, Fellous TG, et al. Fibroblasts of recipient origin contribute to bronchiolitis obliterans in human lung transplants. Am J Respir Crit Care Med 2006;173:1276-82.
46. Direkze N, Forbes SJ, Brittan M, et al. Multiple organ engraftment by bone marrow-derived myofibroblasts in bone marrow-tranplanted mice. Stem Cells 2003;21:514-20.
47. Yamaguchi Y, Kubo T, Murakami M, et al. Bone marrow cells differentiate into wound myofibroblasts and accelerate healing of wounds with exposed bones when combined with an occlusive dressing. Br J Dermatol 2005;152:616-22.
48. Kim CU, Broxmeyer HE. In vitro behavior of hematopoietic progenitor cells under the influence of chemoattractants: stromal cell-derived factor-1, steel factor, and the bone marrow environment. Blood 1998;91:100-10.
49. Petit I, Szyper-Kravitz M, Nagler A, et al. G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4. Nat Immunol. 2002;3: 687-94, Epub 2002 Jun 17. [Erratum in: Nat Immunol 2002;3:787].
50. Kollet O, Shivtiel S, Chen Y-Q, et al. HGF, SDF-1, and MMP-9 are involved in stress-induced human CD34+ stem cell recruitment to the liver. J Clin Invest 2003;112:160-9.
51. Hatch HM, Zheng D, Jorgensen ML, et al. SDF-1 alpha/CXCR4: a mechanism for hepatic oval cell adivation and bone marrow stem cell recruitment to the injured liver of rats. Cloning Stem Cells 2002;4:339-51.
52. Wynn RF, Hart CA, Corradi-Perini C, et al. A small proportion of mesenchymal stem cells strongly expresses functionally active CXCR4 receptor capable of promoting migration to bone marrow. Blood 2004;104:2643-5.
53. Son BR, Marquez-Curtis L, Kucia M, et al. Migration of bone marrow and cord blood mesenchymal stem cells in vitro is regulated by stromal-derived factor-1-CXCR4 and hepatocyte growth factor-c-met axes and involves matrix metalloproteinases. Stem Cells 2006;24:1254-64.
54. Sordi V, Malosio ML, Marchesi F, et al. Bone marrow mesenchymal stem cells express a restricted set of functionally active chemokine receptors capable of promoting migration to pancreatic islets. Blood 2005;106:419-27.
55. Oyagi S, Hirose M, Kojima M, et al. Therapeutic effect of transplanting HGF-treated bone marrow mesenchymal cells into CCL4-injured rats. J Hepatol 2006;44:742-8.
56. Fang B, Shi M, Liao L, et al. Systemic infusion of FLK1+ mesenchymal stem cells ameliorate carbon tetrachloriae-induced liver fibrosis in mice. Transplantation 2004;78:83-8.
57. Sakaida I, Terai S, Yamamoto N, et al. Transplantation of bone marrow cells reduces CCL4- induced fibrosis in mice. Hepatology 2004;40:1304-11.
58. Duffield JS, Forbes SJ, Constandinou CM, et al. Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair. J Clin Invest 2005;115:29-32.
59. Ueno T, Nakamura T, Torimura T, et al. Angiogenic cell therapy for hepatic fibrosis. Med Mol Morphol 2006;39:16-21.
60. Kim WK, Matsumoto K, Bessho K, et al. Growth inhibition and apoptosis in liver myofibroblasts promoted by hepatocyte growth fador leads to resolution from liver cirrhosis. Am J Pathol 2005;166:1017-28.
61. Xia JL, Dai C, Michalopoulos GK, et al. Hepatocyte growth factor attenuates liver fibrosis induced by bile duct ligation. Am J Pathol 2006;168:1500-12.
62. Ge J, Li Y, Qian J, et al. Efficacy of emergent transcatheter transplantation of stem cells for treatment of acute myocardial infarction (TCT-STAMI). Heart 2006;92:1764-7.
63. Bartunek J, Vanderheyden M, Vandekerckhove B, et al. Intracoronary injedion of CD133-positive enriched bone arrow progenitor cells promotes cardiac recovery after recent myocardial infarction: feasibility and safety. Circulation 2005;112(9 Suppl):I178-83.
64. Janssens S, Dubois C, Bogaert J, et al. Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial. Lancet 2006;367:113-21.
65. Lau GK, Suri D, Liang R. Resolution of chronic hepatitis B and anti-HBs seroconversion in humans by adoptive transfer of immunity to hepatitis B core antigen. Gastroenterology 2002;122:614-24.
66. Di Campli C, Piscaglia AC, Giuliante S, et al. No evidence of hematopoietic stem cell mobilization in patients submitted to hepatectomy or in patients with acute on chronic liver failure. Transplant Proc 2005;37:2707-10.
67. Gaia S, Smedile A, Omede P, et al. Feasibility and safety of G-CSF administration to induce bone marrow-derived cells mobilization in patients with end stage liver disease. J Hepatol 2006;45:13-19.
68. am Esch JS 2nd, Knoefel WT, Klein M, et al. Portal application of autologous CD133+ bone marrow cells to the liver: a novel concept to support hepatic regeneration. Stem Cells 2005;23:463-70.
69. Gordon MY, Levicar N, Pai M, et al. Characterisation and clinical application of human CD34+ stem/progenitor cell populations mobilized into the blood by granulocyte colony-stimulating factor. Stem Cells 2006;24:1822-30.
70. Terai S, Ishikawa T, Omori K, et al. Improved liver function in liver cirrhosis patients after autologous bone marrow cell infusion therapy. Stem Cells 2006;24:2292-8.
71. Gasbarrini A, Rapaccini GL, Rutella S, et al. Rescue therapy by portal infusion of autologous stem cells in a case of drug-induced hepatitis. Dig Liver Dis (in press).
72. Houghton J, Stoicov C, Nomura S, et al. Gastric cancer originating from bone marrow-derived cells. Science 2004;306:1568- 71.
73. Direkze NC, Hodivala-Dilke K, Jeffery R, et al. Bone marrow contribution to tumour-associated myofibroblasts ana fibroblasts. Cancer Res 2004;64:8492-5.